NPR Interview, with US Hemp Oil, a Division of CannaVest, Discusses Recent DEA Seed Seizure; Delay of US Into Global Industrial Hemp Market
CNW Group - Tue Jul 22, 8:51AM CDT
CannaVest Corp. (OTCBB: CANV), a leading manufacturer and distributor of hemp and CBD-based products, donated and successfully delivered a shipment of industrial hemp seeds to Kentucky's Murray State University Pilot Cultivation Project. On May 12, 2014, the seeds were planted, and the project was hailed as the first legal hemp field in the United States under the 2014 Farm Bill. Similar shipments by different companies, have been seized by the Drug Enforcement Agency (DEA), which has resulted in State lawmakers and the Kentucky agriculture department taking court action against the Justice Department, the DEA, US Customs and Border Protection and attorney general Eric Holder to force return of the seeds. Today, KPBS reported in a NPR News interview with Chris Boucher, Vice President of US Hemp Oil, LLC (USHO), a subsidiary of CannaVest, that the DEA has seized a shipment of its industrial hemp seeds bound for a farm in Colorado at LAX. The online version of the NPR interview reports that USHO also will "challenge the DEA's latest seizure of its hemp seeds in court," and suggests that this type of political action will be needed to eliminate confusion between Congressional and federal agency enforcement, and to fully realize the potential of the 2014 Farm Bill, as well as the growth and competitiveness of a US hemp industry.
Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Involving CANNAVEST CORP. and Its Board of Directors and a Deadline of June 23, 2014 to Seek a Lead Plaintiff Position -- CANV
GlobeNewswire - Fri Jun 20, 3:01PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased CannaVEST Corp. ("CannaVEST" or the "Company"
CannaVest Corp. Announces Hire of Nutritional Expert, and Evidence-Based Dietary Supplements Authority, Stuart Tomc, to Spearhead Consumer Health Education and Product Development
CNW Group - Thu Jun 19, 9:32AM CDT
Former Global Educator for Nordic NaturalsTM, Joins CannaVest Corp. As Vice President Of Human Nutrition
OTC Sector Trading Focus List: CannaVest Corporation, Medbox, Inc. Tranzbyte Corp, Rapid Fire Marketing, Inc. Right Smile, Inc.
PR Newswire Europe - Wed Jun 11, 6:06AM CDT
LONDON, June 3, 2014 /PRNewswire/ --
CannaVest Reports First Quarter 2014 Financial Results
PR Newswire Europe - Wed Jun 11, 1:22AM CDT
("CannaVest" or "the Company"
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Involving CANNAVEST CORP. and Its Board of Directors and a Deadline of June 23, 2014 to Seek a Lead Plaintiff Position
Business Wire - Tue Jun 10, 5:53PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased CannaVEST Corp. ("CannaVEST" or the "Company"
CannaVest Laboratories, a Subsidiary of CannaVest Corporation, Appoints World Renowned Cannabinoid Scientist Dr. Alexandros Makriyannis To Lead Its Scientific Advisory Board
PR Newswire - Tue Jun 10, 10:23AM CDT
CannaVest Laboratories, a division of CannaVest Corp. (OTC:BB CANV), the producer of the award winning cannabidiol CBD Plus Oil(TM), and the wholly owned subsidiary and laboratory division of CannaVest Corporation, the world's largest industrial hemp and cannabidiol (CBD) oil distribution company- is pleased to announce the appointment of renowned cannabinoid Scientist Dr. Alexandros Makriyannis, to lead its Scientific Advisory Board. Dr. Makriyannis is the current George D. Behrakis Endowed Chair in Pharmaceutical Biotechnology, a Professor of Chemistry, Chemical Biology and Pharmaceutical Sciences, and the Director of the Center for Drug Discovery at Northeastern University. Dr. Makriyannis holds over 40 US Patents, has been a consultant for several major US pharmaceutical companies, and has co-authored over 400 peer-reviewed scientific publications. Through his multidisciplinary work encompassing both chemistry and biology, Dr. Makriyannis has been a pioneer in chemical biology even before this designation was coined. He was among the first to define the biochemical pathways of endocannabinoids within the human endocannabinoid system (ECS). CannaVest Laboratories' lead research scientist Dr. Joshua Hartsel states that, "This historic partnership with Dr. Makriyannis, will enable CannaVest Laboratories to strategically and rapidly expand our capabilities."
INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against CannaVEST Corp.
Business Wire - Tue Jun 10, 9:32AM CDT
Glancy Binkow & Goldberg LLP reminds investors of CannaVEST Corp. ("CannaVEST" or the "Company"
Kirby McInerney LLP Investigates Potential Claims on Behalf of CannaVEST Corp. Investors
Business Wire - Mon Jun 09, 6:49PM CDT
Kirby McInerney LLP announced today that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who acquired CannaVEST Corp. ("CannaVEST" or the "Company"
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of CannaVEST Corp. Of Upcoming Deadline
Business Wire - Mon Jun 09, 12:46PM CDT
Rigrodsky & Long, P.A.:
Donation of Industrial Hemp Seeds by USHO, a Wholly Owned Subsidiary of CannaVest Corporation, Facilitates Planting of First Kentucky State Pilot Project, and First Legal US Industrial Hemp Field, Since 2014 Farm Bill Passage
CNW Group - Thu Jun 05, 9:57AM CDT
Details Of the First US Industrial Hemp Grow, Revealed At Kentucky's Murray State University Press Conference
Abattis Prepaid Card and Mobile App to Revolutionize Marijuana Dispensary Payment Systems
ACCESSWIRE - Tue Jun 03, 12:02PM CDT
WHITEFISH, MT / June 3, 2014 / Abattis Bioceuticals (OTC: ATTBF) (CSE: ATT) is a vertically integrated Canadian International company focused on both the Canadian and American regulated medical marijuana (MMJ) industries. In addition to engaging in activities encompassing cannabis cultivation, production, extraction and refining technologies, as well as quality control, laboratory analysis services and the creation of several derivative products, the company has also taken up a strong position in patient payment technologies via their acquisition of a 34% equity interest (option to acquire 50%) in Instant Payment Systems, LLC (IPS) of Vancouver, WA.